Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
53,310,033
-
Total 13F shares
-
1,798,968
-
Share change
-
+71,778
-
Total reported value
-
$4,545,745
-
Price per share
-
$2.63
-
Number of holders
-
8
-
Value change
-
+$185,000
-
Number of buys
-
6
-
Number of sells
-
3
Institutional Holders of EUPRAXIA PHARMACEUTICALS INC. - Common Shares (EPRX) as of Q3 2024
As of 30 Sep 2024,
EUPRAXIA PHARMACEUTICALS INC. - Common Shares (EPRX) was held by
8 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,798,968 shares.
The largest 8 holders included
SCOTIA CAPITAL INC., Royal Bank of Canada, BANK OF MONTREAL /CAN/, GOLDMAN SACHS GROUP INC, UBS Group AG, 180 WEALTH ADVISORS, LLC, TD Waterhouse Canada Inc., and NATIONAL BANK OF CANADA /FI/.
This page lists
8
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.